Several widely prescribed medications can cause joint pain, ranging from mild stiffness to severe, disabling symptoms. Cholesterol-lowering statins, certain antibiotics, cancer treatments, diabetes drugs, and osteoporosis medications are among the most common culprits. If you’ve recently started a new medication and noticed new or worsening joint pain, the drug itself may be the cause.
Statins (Cholesterol-Lowering Drugs)
Statins are one of the most frequently reported causes of drug-related muscle and joint pain. Up to 30% of patients taking statins experience some form of musculoskeletal symptoms, including fatigue, weakness, and pain. The mechanism involves more than just cholesterol reduction. Statins block an enzyme early in the cholesterol production pathway, which also reduces the body’s production of coenzyme Q10, a molecule critical for energy production inside cells. Without enough of it, muscle cells lose their ability to generate energy efficiently and become more vulnerable to damage.
This energy deficit triggers a cascade of problems: cells struggle to repair themselves, protein breakdown increases, and in some cases, muscle cells begin to die. The result can be anything from a dull ache in the legs to significant weakness that interferes with daily activities. Symptoms can appear within days of starting the medication or develop gradually over weeks to months.
If you develop joint or muscle pain on a statin, the standard approach involves several steps before giving up on statins entirely. Your doctor will typically look for reversible causes first, like an underactive thyroid or a drug interaction that amplifies the statin’s effects. Reducing the dose, switching to a different statin, or taking the medication only two to three times per week instead of daily can resolve symptoms for many people. If none of those strategies work, non-statin cholesterol medications are available as alternatives.
Fluoroquinolone Antibiotics
Fluoroquinolone antibiotics, including ciprofloxacin and levofloxacin, carry an FDA black box warning for tendon damage. These drugs can cause tendonitis and even tendon rupture, most commonly in the Achilles tendon, though the rotator cuff and biceps tendons can also be affected. In children who received these antibiotics during clinical trials, rates of joint pain, arthritis, and gait problems were higher compared to those given other types of antibiotics.
The risk is greatest in people over 60, those taking corticosteroids at the same time, and organ transplant recipients. Symptoms can develop during treatment or even weeks after finishing the course. If you notice tendon pain, swelling, or inflammation while taking one of these antibiotics, you should stop the medication and contact your doctor promptly, as continuing to take it increases the risk of a complete tendon tear.
Aromatase Inhibitors (Breast Cancer Treatment)
Aromatase inhibitors, prescribed to postmenopausal women with hormone-receptor-positive breast cancer, are among the most likely medications to cause joint pain. A pooled analysis of more than 13,000 patients found that 46% developed musculoskeletal symptoms, with individual studies reporting rates as high as 74%.
The condition, known as aromatase inhibitor-associated musculoskeletal syndrome, typically involves joint pain and stiffness, particularly morning stiffness, along with reduced grip strength, carpal tunnel syndrome, and muscle weakness. Symptoms can affect large central joints like the hips, shoulders, and spine, smaller peripheral joints like the wrists and knees, or both. The median onset is about 6 weeks after starting the drug, with symptoms peaking around 6 months. This side effect is a leading reason women discontinue these medications, which are otherwise highly effective at preventing cancer recurrence.
DPP-4 Inhibitors (Diabetes Drugs)
In 2015, the FDA issued a safety warning that DPP-4 inhibitors, a class of type 2 diabetes medications, can cause severe and disabling joint pain. The drugs in this class include sitagliptin, saxagliptin, linagliptin, and alogliptin. Joint pain from these medications can begin shortly after starting treatment or develop after months of use. In reported cases, the pain was significant enough to interfere with daily activities. Symptoms typically resolved after stopping the medication, which is important information if you’re trying to identify whether your diabetes drug is the source of new joint problems.
Bisphosphonates (Osteoporosis Drugs)
Bisphosphonates like alendronate, prescribed to strengthen bones and prevent fractures, can paradoxically cause severe bone, joint, or muscle pain. An FDA postmarketing review identified 118 patients who developed serious musculoskeletal pain after starting oral alendronate, with a median onset of just 14 days, though some cases appeared more than four years into treatment.
Among patients with complete follow-up data, 66% experienced pain relief after stopping the drug. About 11% who tried restarting it saw their pain return. Most patients improved gradually once the medication was discontinued. The pain can be severe enough to be confused with other conditions, so it’s worth noting if your symptoms began shortly after starting an osteoporosis drug.
Cancer Immunotherapy
Immune checkpoint inhibitors, used to treat melanoma, lung cancer, and other cancers, work by releasing the brakes on your immune system so it can attack tumor cells. The downside is that an unleashed immune system can also attack healthy tissue, including joints. Up to 43% of patients in immunotherapy trials reported joint pain, and an estimated 3% to 7.5% developed true inflammatory arthritis that required treatment.
This type of arthritis can persist even after immunotherapy ends. In one study, 75% of patients who developed inflammatory arthritis needed immune-suppressing treatment, including steroids and stronger anti-rheumatic drugs. If the arthritis remained inactive for about six months after stopping immunotherapy, those medications were gradually tapered.
Seizure Medications
Certain anti-seizure drugs, particularly enzyme-inducing types, can disrupt vitamin D metabolism and lead to reduced bone density over time. Vitamin D deficiency was found in 54% of patients on enzyme-inducing seizure medications and 37% of those on non-enzyme-inducing types. Low vitamin D doesn’t cause joint pain directly in every case, but it contributes to bone weakening, fracture risk, and has been linked to conditions like autoimmune arthritis and chronic fatigue that involve joint symptoms. If you take seizure medication long-term, having your vitamin D levels checked can help identify whether a simple supplement might prevent bone and joint complications.
Vaccines (Transient Joint Pain)
Joint pain after vaccination is common but typically short-lived. Following COVID-19 vaccination, inflammatory arthritis was reported at a rate of about 13.8 cases per million doses, with most cases occurring within a median of 2 days after the shot. Women accounted for 72% of reports. This type of joint pain is part of the normal immune response and generally resolves on its own within days to a couple of weeks, distinguishing it from the persistent joint pain caused by the medications listed above.
How to Tell if Your Medication Is the Cause
The clearest sign that a medication is causing your joint pain is timing. If your symptoms started within days to weeks of beginning a new drug, the connection is worth investigating. Different drug classes follow different timelines: antibiotics can trigger symptoms within the first few days, statins and bisphosphonates often within the first two weeks, and aromatase inhibitors typically around six weeks. Some medications, like DPP-4 inhibitors, can cause delayed onset that makes the connection less obvious.
A useful test is whether the pain resolves when the medication is stopped and returns if it’s restarted. This pattern, called a “rechallenge,” is one of the strongest indicators of a drug-related cause. Keep a record of when your joint pain started relative to any medication changes, as this information is valuable for your prescriber when weighing whether to adjust your treatment.